Ophthalmic Emulsion May Safely Clear Postop Inflammation, Reduce Pain

Thursday, January 8, 2009

Comments

Ocular Surgery News

Difluprednate ophthalmic emulsion administered two to four times daily reduced postoperative inflammation and pain with no serious side effects, according to a study.

Full Story

The lesion seen below has been present for many years. The patient does not complain of pain, itching or growth. This is most consistent with:
1. apocrine hydrocystoma
2. basal cell carcinoma
3. chronic dacryocystitis
4. sebaceous cell carcinoma
Check The Answer

VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Ophthalmic Emulsion May Safely Clear Postop Inflammation, Reduce Pain

Comments

Related Categories

Refractive Products and Equipment »

Corneal and Refractive Diagnostics »

Cataract Products and Equipment »

Quick Quiz

The lesion seen below has been present for many years. The patient does not complain of pain, itching or growth. This is most consistent with:

AdGlare RMR Ad

Cataract Featured Products

VISUPLAN 500 Non-Contact Tonometer

SPECTRALIS Diagnostic Imaging Platform

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us